Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
China · Delayed Price · Currency is CNY 28.00
-0.44 (-1.55%)
At close: Jun 2, 2026
SHE:301166 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 2,387 | 2,545 | 2,448 | 3,330 | 3,963 | 8,927 | |
Market Cap Growth | -2.87% | 3.97% | -26.49% | -15.98% | -55.60% | - |
Enterprise Value | 1,258 | 1,281 | 1,081 | 1,931 | 2,407 | 8,756 |
Last Close Price | 28.00 | 29.68 | 28.16 | 37.52 | 43.80 | 97.93 |
PE Ratio | - | - | 241.17 | 82.59 | 37.18 | 82.10 |
PS Ratio | 2.12 | 2.35 | 2.19 | 2.72 | 3.32 | 8.04 |
PB Ratio | 1.20 | 1.27 | 1.18 | 1.57 | 1.84 | 4.28 |
P/TBV Ratio | 1.20 | 1.27 | 1.19 | 1.58 | 1.84 | 4.29 |
P/FCF Ratio | - | - | 513.22 | - | - | 199.64 |
P/OCF Ratio | - | 48.53 | 32.22 | - | - | 151.24 |
EV/Sales Ratio | 1.12 | 1.18 | 0.97 | 1.58 | 2.01 | 7.89 |
EV/EBITDA Ratio | - | - | - | 439.77 | 26.07 | 67.09 |
EV/EBIT Ratio | - | - | - | - | 28.04 | 69.87 |
EV/FCF Ratio | -10.11 | - | 226.72 | - | - | 195.83 |
Debt / Equity Ratio | 0.04 | 0.03 | 0.01 | 0.01 | 0.05 | 0.00 |
Debt / EBITDA Ratio | - | - | - | 1.85 | 1.06 | 0.03 |
Debt / FCF Ratio | - | - | 3.63 | - | - | 0.10 |
Net Debt / Equity Ratio | -0.57 | -0.65 | -0.67 | -0.69 | -0.73 | -0.89 |
Net Debt / EBITDA Ratio | 25.07 | 29.18 | 60.47 | -330.94 | -17.12 | -14.31 |
Net Debt / FCF Ratio | 9.07 | 29.70 | -291.05 | 16.92 | 7.72 | -41.78 |
Asset Turnover | 0.50 | 0.47 | 0.48 | 0.50 | 0.50 | 0.76 |
Inventory Turnover | 6.54 | 6.84 | 5.54 | 5.38 | 7.58 | 13.98 |
Quick Ratio | 5.80 | 6.03 | 7.98 | 7.68 | 7.03 | 9.83 |
Current Ratio | 6.47 | 6.55 | 8.70 | 8.65 | 7.83 | 10.33 |
Return on Equity (ROE) | -1.25% | -1.13% | 0.48% | 1.89% | 5.02% | 8.72% |
Return on Assets (ROA) | -1.73% | -1.67% | -1.01% | -0.16% | 2.24% | 5.39% |
Return on Invested Capital (ROIC) | -7.96% | -8.85% | -5.64% | -1.00% | 17.87% | 51.54% |
Return on Capital Employed (ROCE) | -3.10% | -3.00% | -1.80% | -0.30% | 3.90% | 6.00% |
Earnings Yield | -1.06% | -0.90% | 0.41% | 1.21% | 2.69% | 1.22% |
FCF Yield | -5.21% | -1.71% | 0.19% | -2.58% | -5.17% | 0.50% |
Dividend Yield | 2.11% | 2.02% | 0.82% | 1.25% | 2.05% | 0.51% |
Payout Ratio | - | - | 401.20% | 195.54% | 41.52% | 18.58% |
Buyback Yield / Dilution | -2.65% | -4.36% | 1.41% | 1.02% | -32.32% | -1.05% |
Total Shareholder Return | -0.55% | -2.34% | 2.23% | 2.27% | -30.26% | -0.54% |